P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
